510(k) Report

510(k) · Cleared

Cleared

Eon 100 Chemistry Analyzer with Ise , Model 77105, Bicarbonate Reagent, Model 77475

K100060510(k) TraditionalCleared Dec 15, 2010338-day reviewClass II21 CFR 862.1160

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vital Diagnostics (Manufacturing) Ptyltd · KHS Enzymatic, Carbon-Dioxide

Cleared on Dec 15, 2010 after a 338-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Dec 15, 2010
Review
338 days
Class
Class II
Product code
KHS
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K100060Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KHS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All KHS devices

KHS Enzymatic, Carbon-Dioxide: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · KHS

1in 2017

2007: 22008: 12009: 12010: 32011: 12012: 22013: 22014: 12016: 12017: 1
2007high 3 (2010) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KHS

143in 2010

2010: 143 days median
2007high 143 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KHS

1in 2025

2013: 12019: 12023: 12025: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KHS

40in 2025

2008: 22009: 142011: 52012: 32013: 22014: 62015: 12016: 42017: 72018: 152019: 352020: 312021: 142022: 102023: 252024: 302025: 40
2007high 40 (2025) · low 0 (2007)2025

MAUDE reports naming product code KHS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—02
20091—014
2010314300
20111—05
20122—03
20132—12
20141—06
20150—01
20161—04
20171—07
20180—015
20190—135
20200—031
20210—014
20220—010
20230—125
20240—030
20250—140
20260—0—

What is it indicated for?

The Eon 100 is a discrete photometric chemistry analyzer for clinical use. It is a device intended for the in-vitro, spectrophotometric determination of general chemistry assays. The Eon 100 has replaceable parts, automated maintenance monitoring and backup of both patient and system data. The Eon 100 Chemistry Analyzer is intended to be used to assist the clinician with the diagnosis of disease or other conditions, including a determination of the state…

Read the full statement (638 words)

The Eon 100 is a discrete photometric chemistry analyzer for clinical use. It is a device intended for the in-vitro, spectrophotometric determination of general chemistry assays. The Eon 100 has replaceable parts, automated maintenance monitoring and backup of both patient and system data.

The Eon 100 Chemistry Analyzer is intended to be used to assist the clinician with the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease.

The Eon 100 includes an optional Ion Selective Electrodes (ISE) module for the measurement of sodium, potassium and chloride in serum and plasma.

The Eon 100 is for in vitro diagnostic use only.

An amylase test system is a device intended to measure the quantitative activity of the enzyme amylase in serum and plasma on the EON 100 Chemistry Analyzer. Amylase measurements are used primarily for the diagnosis and treatment of pancreatitis (inflammation of the pancreas).

An albumin test system is a device intended to quantitatively measure the albumin concentration in serum and plasma on the EON 100 Chemistry Analyzer. Albumin measurements are used in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys.

A bicarbonate/carbon dioxide test system is a device intended to quantitatively measure bicarbonate/carbon dioxide in serum and plasma on the EON 100 Chemistry Analyzer. Bicarbonate/carbon dioxide measurements are used in the diagnosis and treatment of numerous potentially serious disorders associated with changes in body acid-base balance.

Sodium

A sodium test system is a device intended to quantitatively measure sodium in serum and plasma on the EON 100 Chemistry Analyzer. Measurements obtained by this device are used in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excretion of large amounts of dilute urine, accompanied by extreme thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance.

Potassium

A potassium test system is a device intended to quantitatively measure potassium in serum and plasma on the EON 100 Chemistry Analyzer. Measurements obtained by this device are used to monitor electrolyte balance in the diagnosis and treatment of diseases conditions characterized by low or high blood potassium levels.

Chloride

A chloride test system is a device intended to quantitatively measure the level of chloride in serum and plasma on the EON 100 Chemistry Analyzer. Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis

A Total protein test system is a device intended to quantitatively measure total protein(s) in serum and plasma on the EON 100 Chemistry Analyzer. Measurements obtained by this device are used in the diagnosis and treatment of a variety of diseases involving the liver, kidney, or bone marrow as well as other metabolic or nutritional disorders.

A Uric acid test system is a device intended to quantitatively measure uric acid in serum and plasma on the EON 100 Chemistry Analyzer. Measurements obtained by this device are used in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and of patients receiving cytotoxic drugs.

The Eon Calbrator Kit is a device intended for medical purposes for use in a test system to establish points of reference for albumin, total protein, and uric acid on the EON 100 Chemistry Analyzer that are used in the determination of values in the measurement of substances in human specimens.

The Eon Carbon Dioxide Calibrator is a device intended for medical purposes for use in the Eon Carbon Dioxide Reagent assay on the EON 100 Chemistry Analyzer to establish points of reference that are used in the determination of values in the measurement of carbon dioxide in serum and plasma.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K100060: Eon 100 Chemistry Analyzer with Ise , Model 77105, Bicarbonate Reagent, Model 77475.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K100060

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026